Civeo Corp current report, 26 July 2022

Civeo Corp Form 8-K Summary

Business Context and Reporting Period

This Form 8-K was filed by Civeo Corporation on July 26, 2022. The report discloses a specific executive compensation arrangement rather than periodic financial results.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on a contractual agreement with an executive officer.

Material Changes

On July 26, 2022, the Company entered into a Retention Commitment Agreement with Allan D. Schoening, Senior Vice President, Canada. This agreement establishes specific severance and retention terms effective until June 30, 2024.

Management Commentary and Contingencies

The agreement outlines the following contingencies and benefits if Mr. Schoening's employment is terminated without "cause" prior to the Retention Date:

  • A cash lump sum equal to base salary from the termination date through June 30, 2024.
  • A cash lump sum equal to target bonuses for prior periods plus a pro-rated target bonus for 2024.
  • Accelerated vesting of all outstanding equity awards, excluding performance-based awards which remain subject to performance metrics.
  • Continued medical and dental benefits at pre-termination levels until the Retention Date.

If employment terminates after the Retention Date, Mr. Schoening may elect a consulting role where equity continues to vest. If the consulting relationship ends without cause, all unvested equity accelerates. In the event of a change in control prior to the Retention Date, the existing Executive Change of Control Severance Agreement supersedes this new agreement.

Investor Verification Checklist

  • Review the full text of the Retention Commitment Agreement (Exhibit 10.1) for specific definitions of "cause" and "change in control."
  • Verify the total potential cash and equity liability associated with this agreement relative to the company's current cash position.
  • Confirm the status of Mr. Schoening's existing Executive Change of Control Severance Agreement dated July 13, 2015.
  • Assess the impact of accelerated equity vesting on future dilution if a termination event occurs.